Author: Shannon Palus

Prostate cancer paper retracted after investigation can’t review original image

1.coverAn article about how a COX-2 inhibitor (celecoxib) inhibits growth of prostate cancer in rats is being retracted after the authors were unable to provide an investigation committee at New York University with the backup they were asking for.

When the paper was published in 2003, first author Bhagavathi Narayanan worked at the Institute for Cancer Prevention in New York (also known as the American Health Foundation). But when the institute went broke the next year — thanks partly to lavish salaries and offices, as the New York Post reported —  the authors claim they could no longer obtain back up for an image in the paper, once it was questioned years later by NYU, where Narayanan is now based.

Here’s the retraction note, published in Clinical Cancer Research:

Continue reading Prostate cancer paper retracted after investigation can’t review original image

Inventors have a dust up over air sampling device

graphic_amt_cover_homepageTo climate scientist Pieter Tans, a “novel” air sampling device in a recent paper looked a little too familiar. Specifically, like a device that he had invented — the AirCore, which he calls a “tape recorder” for air.

The journal editors came up with a unique solution to the disagreement that followed, which the editor in chief called “rather unclear:” The journal ran an editorial in which both Tans and the authors of the paper contend that their device is unique.

The paper in question, “A novel Whole Air Sample Profiler (WASP) for the quantification of volatile organic compounds in the boundary layer,” was published in Atmospheric Measurement Techniques. It has not been cited, according to Thomson Scientific’s Web of Knowledge.

It now bears a note, in bold and red: “Please read the Editorial Note before accessing the paper.” 

Here’s how the editorial laid out the case:

Continue reading Inventors have a dust up over air sampling device

We have a new record: 80 years from publication to retraction

cover_2015_51We have a new record for the longest time from publication to retraction: 80 years. It’s for a case report about a 24-year-old man who died after coughing up more than four cups of what apparently looked — and smelled — like pee.

According to the case report titled “Een geval van uroptoë” published in 1923, an autopsy revealed that the man had a kidney that was strangely located in his chest cavity. A case of pneumonia caused the kidney to leak urine into the space around his lungs, leading to the perplexing cough.

If that sounds too crazy to be true, you’re right: This man never existed. The case was retracted in 2003. (Yes, we are a little late to this one — it recently popped up in one of our Google alerts.)

A write-up by the editors of the Nederlands Tijdschrift voor Geneeskunde — that translates to “Dutch Journal of Medicine” — explains that the strange case was a fake (on the fifth page of this PDF, in English):

Continue reading We have a new record: 80 years from publication to retraction

Nature retracts paper six years after it was flagged for fraud

cover_natureNature retracted a paper on protein structures today, six years after an investigation at the University of Alabama identified several structures that were “more likely than not falsified and/or fabricated” by one of the authors.

The paper came under scrutiny soon after it was published in 2006. A letter published in Nature that same year pointed out “physically implausible features in the structures it described.” That triggered the investigation at the University of Alabama, the result of which was published in 2009, identifying “nine publications related to the same protein structures that should be retracted from various scientific journals.” Everything was pinned on last author H.M. Krishna Murthy, who the investigation determined was “solely responsible for the fraudulent data.”

A 2009 Nature news article on the investigation declared that the “fraud is the largest ever in protein crystallography.”

We’re not sure what took Nature so long to retract the letter, titled “The structure of complement C3b provides insights into complement activation and regulation.” Here’s the note, which explains that not all the authors agreed to the retraction:

Continue reading Nature retracts paper six years after it was flagged for fraud

Third retraction appears for Leiden researcher fired in 2013

Screen Shot 2015-12-21 at 12.18.41 PM

A researcher who was fired from Leiden University Medical Center in 2013 for fraud has notched a third retraction, following an investigation by her former workplace.

When Leiden fired Annemie Schuerwegh, they announced two retractions of papers that contained manipulated data. This third retraction — the last, according to a spokesperson for the center  — is for “a discrepancy between the data reported in the article and the original collected data,” per the note.

The 2011 paper, “Mast cells are the main interleukin 17-positive cells in anticitrullinated protein antibody-positive and -negative rheumatoid arthritis and osteoarthritis synovium” published in Arthritis Research & Therapy, suggests the source of a protein involved in rheumatoid arthritis. It has been cited 51 times, according to Thomson Scientific’s Web of Knowledge.

Here’s the retraction note:

Continue reading Third retraction appears for Leiden researcher fired in 2013

Voinnet’s notice count grows, as he notches his 18th correction

home_coverOlivier Voinnet, a high-profile plant scientist at ETH Zurich, has earned a mega-correction. It wrapped up a rough year for the biologist, which included his seventh retraction, and a CNRS investigation that found evidence of misconduct.

This latest correction, to a paper on the mechanisms behind RNA silencing in Arabidopsis, was published in RNA. The 2007 paper has been cited 101 times, according to Thomson Scientific’s Web of Knowledge. The corrigendum modifies three figures in total.

The notice is long, so we’re not going to post the whole thing here. The first error in “Transitivity in Arabidopsis can be primed, requires the redundant action of the antiviral Dicer-like 4 and Dicer-like 2, and is compromised by viral-encoded suppressor proteins” is a clarification to a legend:

Continue reading Voinnet’s notice count grows, as he notches his 18th correction

Stem cell researcher that sued Harvard failed to disclose conflicts on 6 publications

Piero Anversa, a stem cell researcher who we recently learned is leaving Harvard and Brigham & Women’s Hospital after suing them, has added a disclosure statement to six publications.

The four papers and two letters were published in Circulation, and all bear identical corrections:

Piero Anversa, MD, discloses that he is a member of Analogous, LLC.

The author regrets this omission.

Trouble is, we can’t find a company by that name. What we do know:

Continue reading Stem cell researcher that sued Harvard failed to disclose conflicts on 6 publications

Author retracts statements about gay conversion therapy

Screen Shot 2015-12-17 at 1.49.17 PM

Key assertions in a paper on homosexuality have been removed from the Journal of the Islamic Medical Association of North America, in what the notice describes as a “partial retraction.”

The 2006 article “Homosexuality: An Islamic Perspective,” states that conversion therapy can be effective, and that gay people have poorer health. Those statements are among those that lack evidence, according to a note on the paper published in July. The retraction pulls those assertions, among others, and instead argues that a homosexual person should be helped to “accept his or her LGB identity,” and find a welcoming community.

The 2006 article is definitely a perspective — it states the opinion of the sole author, M. Basheer Ahmed, who has a private psychiatry practice in Texas, as to whether homosexuality is a choice. He thinks yes, though the science on the matter is fairly clear that it’s not.

But we still think it’s interesting that a journal chose to take back some of the statements contained in the article. Here’s the abstract from the “partial retraction” note:

Continue reading Author retracts statements about gay conversion therapy

Journal bans authors following investigation confirming plagiarism

Screen Shot 2015-12-07 at 4.46.43 PMA journal has banned three researchers after an investigation confirmed that a “significant portion” of the text of their paper on screening for urinary tract infections had been plagiarized.

The researchers Sreenivasan Srirangaraj, Arunava Kali and MV Pravin Charles, who are all based in India, won’t be allowed to publish in Australasian Medical Journal in the future, according to the retraction note.  

The retraction note takes the form of a letter from the Editor in Chief of the journal:

Continue reading Journal bans authors following investigation confirming plagiarism

JAMA retracts osteoporosis paper with manipulated data

Screen Shot 2015-12-29 at 10.48.49 AMA JAMA study on an inexpensive treatment for osteoporosis has been retracted because the first author falsified or fabricated data. We’ve been expecting this one: An investigation at Women’s College Hospital in Toronto, the bone researcher’s former workplace, had already revealed issues with the paper.

An internal memo sent to staff (available in full here) in October explained that the investigation had found “unequivocal evidence of systematic data manipulation” by Sophie Jamal, who had already resigned from her positions at WCH and the University of Toronto.

The study appeared to show that nitroglycerin ointment could have a small positive effect on bone mineral density in postmenopausal patients. It’s been cited 30 times, according to Thomson Scientific’s web of Knowledge. (That’s two more times than when we last reported on the paper: It was cited once by the investigation, and once by a paper that was published earlier in October, but had not yet been indexed.)

Here’s the retraction note for “Effect of Nitroglycerin Ointment on Bone Density and Strength in Postmenopausal Women: A Randomized Trial:”

Continue reading JAMA retracts osteoporosis paper with manipulated data